SAP130 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.276800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.827000E-01
Normal-vs-Stage2
7.578400E-01
Normal-vs-Stage3
1.753370E-01
Normal-vs-Stage4
3.286000E-01
Stage1-vs-Stage2
2.629600E-01
Stage1-vs-Stage3
5.329200E-01
Stage1-vs-Stage4
2.740000E-02
Stage2-vs-Stage3
1.453380E-01
Stage2-vs-Stage4
4.233800E-02
Stage3-vs-Stage4
4.874300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.097800E-01
Normal-vs-AfricanAmerican
9.778400E-01
Normal-vs-Asian
6.631600E-01
Caucasian-vs-AfricanAmerican
6.319600E-01
Caucasian-vs-Asian
7.556000E-01
AfricanAmerican-vs-Asian
5.923000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.480400E-01
Normal-vs-Female
7.046800E-01
Male-vs-Female
7.308600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.510000E-01
Normal-vs-Age(41-60Yrs)
9.279000E-01
Normal-vs-Age(61-80Yrs)
5.983800E-01
Normal-vs-Age(81-100Yrs)
5.869400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.859380E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.105800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.674600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.834100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.498600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.522600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.602800E-01
Normal-vs-Daily Drinker
4.358400E-01
Normal-vs-Weekly Drinker
7.698200E-01
Normal-vs-Occasional Drinker
8.090200E-01
Normal-vs-Social Drinker
7.704400E-01
Non Drinker-vs-Daily Drinker
9.048000E-01
Non Drinker-vs-Weekly Drinker
3.913700E-02
Non Drinker-vs-Occasional Drinker
2.459800E-02
Non Drinker-vs-Social Drinker
1.705960E-01
Daily Drinker-vs-Weekly Drinker
7.818000E-02
Daily Drinker-vs-Occasional Drinker
5.462100E-02
Daily Drinker-vs-Social Drinker
2.561000E-01
Weekly Drinker-vs-Occasional Drinker
7.927000E-01
Weekly Drinker-vs-Social Drinker
3.705000E-01
Occasional Drinker-vs-Social Drinker
3.654400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.635600E-01
Normal-vs-Grade 2
9.468200E-01
Normal-vs-Grade 3
9.737400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.654000E-02
Grade 1-vs-Grade 3
1.074060E-02
Grade 1-vs-Grade 4
8.635600E-01
Grade 2-vs-Grade 3
4.133400E-01
Grade 2-vs-Grade 4
9.468200E-01
Grade 3-vs-Grade 4
9.737400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.639400E-01
Normal-vs-NonDiabetic
6.878200E-01
Diabetic-vs-NonDiabetic
7.586800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.245400E-01
Normal-vs-NoPancreatitis
6.907400E-01
Pancreatitis-vs-NoPancreatitis
7.159800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.957400E-01
Normal-vs-N1
7.647200E-01
N0-vs-N1
8.137400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.332000E-01
Normal-vs-TP53-NonMutant
8.207200E-01
TP53-Mutant-vs-TP53-NonMutant
2.202000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
